• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《拯救脓毒症运动:危重症 2019 冠状病毒病研究重点》。

The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness.

机构信息

Department of Surgery and Emory Critical Care Center, Emory University, Atlanta, GA.

Department of Anesthesiology Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Italy.

出版信息

Crit Care Med. 2021 Apr 1;49(4):598-622. doi: 10.1097/CCM.0000000000004895.

DOI:10.1097/CCM.0000000000004895
PMID:33591008
Abstract

OBJECTIVES

To identify research priorities in the management, pathophysiology, and host response of coronavirus disease 2019 in critically ill patients.

DESIGN

The Surviving Sepsis Research Committee, a multiprofessional group of 17 international experts representing the European Society of Intensive Care Medicine and Society of Critical Care Medicine, was virtually convened during the coronavirus disease 2019 pandemic. The committee iteratively developed the recommendations and subsequent document.

METHODS

Each committee member submitted a list of what they believed were the most important priorities for coronavirus disease 2019 research. The entire committee voted on 58 submitted questions to determine top priorities for coronavirus disease 2019 research.

RESULTS

The Surviving Sepsis Research Committee provides 13 priorities for coronavirus disease 2019. Of these, the top six priorities were identified and include the following questions: 1) Should the approach to ventilator management differ from the standard approach in patients with acute hypoxic respiratory failure?, 2) Can the host response be modulated for therapeutic benefit?, 3) What specific cells are directly targeted by severe acute respiratory syndrome coronavirus 2, and how do these cells respond?, 4) Can early data be used to predict outcomes of coronavirus disease 2019 and, by extension, to guide therapies?, 5) What is the role of prone positioning and noninvasive ventilation in nonventilated patients with coronavirus disease?, and 6) Which interventions are best to use for viral load modulation and when should they be given?

CONCLUSIONS

Although knowledge of both biology and treatment has increased exponentially in the first year of the coronavirus disease 2019 pandemic, significant knowledge gaps remain. The research priorities identified represent a roadmap for investigation in coronavirus disease 2019.

摘要

目的

确定危重症 2019 年冠状病毒病患者管理、发病机制和宿主反应方面的研究重点。

设计

由 17 名国际专家组成的多专业幸存脓毒症研究委员会代表欧洲重症监护医学学会和重症监护医学学会,在 2019 年冠状病毒病大流行期间以虚拟方式召开会议。委员会对建议和后续文件进行了反复修订。

方法

每位委员会成员提交一份他们认为 2019 年冠状病毒病最重要的研究重点清单。全体委员会对提交的 58 个问题进行投票,以确定 2019 年冠状病毒病研究的首要重点。

结果

幸存脓毒症研究委员会为 2019 年冠状病毒病提供了 13 项研究重点。其中,确定了前六个重点,包括以下问题:1)呼吸机管理方法是否应与急性低氧性呼吸衰竭患者的标准方法有所不同?2)宿主反应能否通过治疗获益进行调节?3)严重急性呼吸综合征冠状病毒 2 直接靶向哪些特定细胞,这些细胞如何反应?4)早期数据能否用于预测 2019 年冠状病毒病的结局,并进一步指导治疗?5)俯卧位和无创通气在非通气 2019 年冠状病毒病患者中的作用如何?6)用于病毒载量调节的最佳干预措施是什么,以及何时给予?

结论

尽管在 2019 年冠状病毒病大流行的第一年,生物学和治疗方面的知识呈指数级增长,但仍存在重大知识空白。确定的研究重点代表了 2019 年冠状病毒病研究的路线图。

相似文献

1
The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness.《拯救脓毒症运动:危重症 2019 冠状病毒病研究重点》。
Crit Care Med. 2021 Apr 1;49(4):598-622. doi: 10.1097/CCM.0000000000004895.
2
Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock.拯救脓毒症运动:脓毒症和脓毒性休克的研究重点。
Crit Care Med. 2018 Aug;46(8):1334-1356. doi: 10.1097/CCM.0000000000003225.
3
Surviving Sepsis Campaign Research Priorities 2023.拯救脓毒症运动 2023 年研究重点。
Crit Care Med. 2024 Feb 1;52(2):268-296. doi: 10.1097/CCM.0000000000006135. Epub 2024 Jan 19.
4
Surviving sepsis campaign: research priorities for sepsis and septic shock.拯救脓毒症运动:脓毒症和脓毒性休克的研究重点。
Intensive Care Med. 2018 Sep;44(9):1400-1426. doi: 10.1007/s00134-018-5175-z. Epub 2018 Jul 3.
5
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.《拯救脓毒症运动:成人 ICU 中 2019 年冠状病毒病(COVID-19)管理指南》:第一版更新。
Crit Care Med. 2021 Mar 1;49(3):e219-e234. doi: 10.1097/CCM.0000000000004899.
6
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
7
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).拯救脓毒症运动:2019 冠状病毒病(COVID-19)危重症成人管理指南。
Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.
8
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.拯救脓毒症运动:严重脓毒症和脓毒性休克治疗国际指南:2008年版
Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41.
9
The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis.拯救脓毒症运动:脓毒症管理、流行病学、评分及识别方面的研究重点
Intensive Care Med Exp. 2021 Jul 2;9(1):34. doi: 10.1186/s40635-021-00400-z.
10
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症和脓毒性休克管理国际指南:2016 年版。
Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.

引用本文的文献

1
Research prioritisation in preparedness for and response to outbreaks of high-consequence pathogens: a scoping review.针对高后果病原体爆发的防范与应对中的研究优先级设定:一项范围综述
BMC Med. 2025 Mar 10;23(1):147. doi: 10.1186/s12916-025-03973-8.
2
SARS-CoV-2 pathophysiology and post-vaccination severity: a systematic review.严重急性呼吸综合征冠状病毒2的病理生理学与疫苗接种后的严重程度:一项系统综述
Immunol Res. 2024 Dec 18;73(1):17. doi: 10.1007/s12026-024-09553-x.
3
Atypical Complications during the Course of COVID-19: A Comprehensive Review.
COVID-19 病程中的非典型并发症:全面综述。
Medicina (Kaunas). 2024 Jan 15;60(1):164. doi: 10.3390/medicina60010164.
4
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2.一种新型吲哚 - 3 - 羧酸衍生物对严重急性呼吸综合征冠状病毒2的体外抗病毒活性
Acta Naturae. 2023 Oct-Dec;15(4):83-91. doi: 10.32607/actanaturae.26623.
5
Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19.人类血管紧张素转换酶 2 的遗传变异与 2019 冠状病毒病易感性。
Genet Res (Camb). 2023 Nov 29;2023:2593199. doi: 10.1155/2023/2593199. eCollection 2023.
6
A Comparison of the Adverse Effects and Utility of Different Monoclonal Antibodies for SARS-CoV-2: A Retrospective Cohort Study.不同单克隆抗体治疗新型冠状病毒肺炎的不良反应及效用比较:一项回顾性队列研究
Cureus. 2023 Aug 7;15(8):e43094. doi: 10.7759/cureus.43094. eCollection 2023 Aug.
7
Vaccination is the most effective and best way to avoid the disease of COVID-19.接种疫苗是避免感染 COVID-19 疾病最有效和最好的方法。
Immun Inflamm Dis. 2023 Aug;11(8):e946. doi: 10.1002/iid3.946.
8
COVID-19 of differing severity: from bulk to single-cell expression data analysis.不同严重程度的 COVID-19:从批量到单细胞表达数据分析。
Cell Cycle. 2023 Jul-Aug;22(14-16):1777-1797. doi: 10.1080/15384101.2023.2239620. Epub 2023 Jul 24.
9
Efficacy and safety of awake prone positioning in the treatment of non-intubated spontaneously breathing patients with COVID-19-related acute respiratory failure: A systematic review and meta-analysis.清醒俯卧位通气治疗新型冠状病毒肺炎相关急性呼吸衰竭非插管自主呼吸患者的疗效与安全性:一项系统评价与荟萃分析
J Intensive Med. 2023 Mar 30;3(4):365-72. doi: 10.1016/j.jointm.2023.02.001.
10
Mechanical power normalized to aerated lung predicts noninvasive ventilation failure and death and contributes to the benefits of proning in COVID-19 hypoxemic respiratory failure.以通气肺为标准的机械功率可预测无创通气失败和死亡,并有助于俯卧位通气对新型冠状病毒肺炎低氧性呼吸衰竭的治疗效果。
EPMA J. 2023 Jun 10;14(3):1-39. doi: 10.1007/s13167-023-00325-5.